Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Danaher has entered into a definitive agreement with General Electric Company (GE) to acquire the Biopharma business of GE Life Sciences (GE Biopharma) for a cash purchase price of approximately $21.4 billion.
read more
Danaher Corporation announced that Danaher has entered into a definitive agreement to acquire privately-held Aldevron, for a cash purchase price of approximately $9.6 billion. Danaher expects to finance the acquisition using cash on hand and/or ...
read more
Dalton Pharma Services announced that the FDA completed a PAI inspection of its Health-Canada licensed manufacturing facility in Canada, in January 2019.
read more
Wednesday, January 28, 2015
Dalton Pharma Services today announced expanded cGMP sterile powder filling capabilities as part of its ongoing focus on sterile processing and manufacturing.
read more
Monday, November 26, 2018
Dalton Pharma announced a drug development and manufacturing services agreement with ExCellThera, a biotechnology company focused on delivering molecules and bioengineering solutions.
read more
Dalton Pharma Services has announced the signing of a drug development and manufacturing services agreement with Oryn Therapeutics.
read more
Dalton Pharma Services has declared the signing of a drug development and manufacturing services agreement with Oryn Therapeutics, an American biotechnology firm.
read more
Wednesday, December 15, 2021
Gamma Biosciences, a global life sciences company serving the academic and advanced therapy market, announced the appointment of Dale Gordon as Chief Executive Officer (CEO) of its operating company Mirus Bio. Gordon succeeds founders Jon Wolff and ...
read more
Thursday, October 14, 2021
The Department of Air Force, in coordination with the Department of Health and Human Services (HHS), awarded a $30 million contract to Eurofins Genomics US to build a new production facility and expanded capacity for the manufacturing of reagents ...
read more
Wednesday, October 31, 2012
Cytovance Biologics, Inc. and Fountain BioPharma, Inc. jointly announce the execution of a Biopharmaceutical Development and Manufacturing collaboration for FB301, a novel monoclonal antibody (mAb) being developed for the treatment of allergy as a ...
read more
Cytovance® Biologics, a leading full-service contract manufacturer (“CMO”) of mammalian and microbial biologics, announces Don Wuchterl as the new Senior Vice President of Manufacturing Operations
read more
Cytovance Biologics, Inc. announces that it has teamed up with NeuroFx to develop and manufacture stem cell derived, cell-free therapy for neurological conditions.
read more
Cytovance Biologics, Inc., a leading full-service contract manufacturer ("CMO") of mammalian and microbial biologics, is pleased to participate in the Buzz of BIO for the 2014 BIO International Convention. Hosted by the Biotechnology Industry ...
read more
Wednesday, January 14, 2015
Cytovance® Biologics, Inc., a leading biopharmaceutical contract manufacturing company, announced the promotion of Donald Wuchterl to Chief Operating Officer. In this new capacity, Mr. Wuchterl will oversee Cytovance's Research & Development Services...
read more
Wednesday, January 14, 2015
Cytovance Biologics, Inc. is pleased to announce the appointment of Seth Fisher as Director of Purification Development in the R&D Services group.
read more